| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 05/19/2010 | CN101708292A Chinese medicament for treating rheumatic and rheumatoid diseases |
| 05/19/2010 | CN101708288A Chinese medicinal decoction for treating cervical spondylosis with vertigo |
| 05/19/2010 | CN101708269A Liniment medicament for treating traumatic injuries |
| 05/19/2010 | CN101708266A Oral herbal decoction for treating osteoporosis |
| 05/19/2010 | CN101708265A Rheumatism curing powder |
| 05/19/2010 | CN101708264A Chinese medicinal composition for treating lumbar and cervical disc herniation and spinal stenosis |
| 05/19/2010 | CN101708261A Chinese medicinal patch for treating stiff neck |
| 05/19/2010 | CN101708259A Hongshang powder |
| 05/19/2010 | CN101708258A Medicament for treating bone damage |
| 05/19/2010 | CN101708254A Chinese medicinal decoction for treating chronic lumbar vertebrae anti-pain lateral curvatura |
| 05/19/2010 | CN101708251A Method for granulating medicament for treating osteoporosis |
| 05/19/2010 | CN101708245A Hyperosteogeny applying liquid |
| 05/19/2010 | CN101708232A Externally applied medicated wine for rheumatic ostalgia |
| 05/19/2010 | CN101708221A Chinese medicinal liquor for treating osteomyelitis |
| 05/19/2010 | CN101708208A Quality control method of capsule preparation for treating a painful swollen joint |
| 05/19/2010 | CN101708166A Cefpodoxime proxetil submicron emulsion solid preparation and novel application thereof |
| 05/19/2010 | CN101708165A Microspheres for active embolization |
| 05/19/2010 | CN101708160A Pamidronate disodium suspension injection |
| 05/19/2010 | CN101204531B Medicament composite for ANFH |
| 05/19/2010 | CN101199799B Healthy kidney Xifeng tea |
| 05/19/2010 | CN101195020B Externally used medical ointment for treating rheumatism, traumatic injury |
| 05/19/2010 | CN101195018B Medicament for treating bone joint disease |
| 05/19/2010 | CN101181506B Liquid medicine for curing wound |
| 05/19/2010 | CN101167777B Composite medicine for treating traumatic injury and its preparing process |
| 05/19/2010 | CN101164585B Medicine for curing gout and its preparing method |
| 05/19/2010 | CN101152446B Medical ointment for treating hyperosteogeny |
| 05/19/2010 | CN101129630B Medicament for treating rheumatism, arthritis pauperum |
| 05/19/2010 | CN101112498B Chinese traditional medicine having functions of promoting blood circulation, relaxing vein and strengthening muscles and bones and method for preparing the same |
| 05/19/2010 | CN101099820B External-applied medicine for treating injury and bone fracture |
| 05/19/2010 | CN101095844B Chinese traditional medicine preparations for treating hyperosteogeny and method for preparing the same |
| 05/19/2010 | CN101095786B Hyperplasia hernia ion rehabilitating ointment and method for preparing the same |
| 05/19/2010 | CN101095785B Chinese traditional medicine composition for treating arthritis hyperosteogeny intervertebral disc protrusion |
| 05/19/2010 | CN101085181B Plaster for treating bony spur and osteoproliferation and preparation method thereof |
| 05/19/2010 | CN101085114B Curculigo orchioides total phenolic glycoside with resisting osteoporosis activity |
| 05/19/2010 | CN101085078B Exterior-applied medicine liquid for treating osteoarthrilis |
| 05/19/2010 | CN101040922B Chinese traditional medicine compound for treating gout |
| 05/19/2010 | CN101036691B Health-caring product for improving bone density and immunity |
| 05/19/2010 | CN101032610B Medicinal liquor with Chinese medicine for treating rheumatoid disease and its preparation |
| 05/19/2010 | CN101032580B Medicine for treating rheumatic diseases |
| 05/19/2010 | CN101028504B Gubiping instant granules and production thereof |
| 05/19/2010 | CN101028472B Oral Chinese medicinal composition for treating lumbocostal overstrain |
| 05/19/2010 | CN101024003B Medicine for treating injury and preparing method |
| 05/19/2010 | CN101007040B External applied medicine for treating bone fractures |
| 05/18/2010 | US7718776 Comprises monoclonal antibody which specifically binds osteoprotegerin ligand (OPGL) for diagnosis, prevention and treatment of bone disorders |
| 05/18/2010 | US7718702 Cannabinoid receptor ligands |
| 05/18/2010 | US7718673 Heterocyclic amides such as beta-(((1-(4-((4,5-dihydro-1H-imidazol-2-yl)amino)-1-oxobutyl)-4 -piperidinyl)carbonyl)amino) -,(beta 3S)-3-quinolinepropanoic acid, used as antagonists for cellular adhesion molecules |
| 05/18/2010 | US7718634 Method of treatment using bisphosphonic acid |
| 05/18/2010 | US7718606 Methods for treating muscle diseases and disorders |
| 05/18/2010 | US7718387 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays |
| 05/18/2010 | US7718376 Identification and isolation of somatic stem cells and uses thereof |
| 05/18/2010 | US7718177 Antibodies directed to fragments of connective tissue growth factor (CTGF) polypeptide and methods and uses thereof |
| 05/18/2010 | CA2585027C Process for the preparation of bisphosphonates |
| 05/18/2010 | CA2472475C 17-hydroxy-4-aza-androstan-3-ones as androgen receptor modulators |
| 05/18/2010 | CA2465247C Benzimidazoles and analogues and their use as protein kinases inhibitors |
| 05/18/2010 | CA2422371C Pyrazole compounds useful as protein kinase inhibitors |
| 05/18/2010 | CA2422367C Pyrazole compounds useful as protein kinase inhibitors |
| 05/18/2010 | CA2368965C Recombinant il-18 antagonists useful in treatment of il-18 mediated disorders |
| 05/18/2010 | CA2304204C Quinoline-containing .alpha.-ketoamide cysteine and serine protease inhibitors |
| 05/18/2010 | CA2302808C 50 human secreted proteins |
| 05/18/2010 | CA2296409C Agents comprising midkine or its inhibitor as active ingredient |
| 05/18/2010 | CA2259143C G-beta-gamma regulated phosphatidylinositol-3' kinase p101 regulatory subunit |
| 05/18/2010 | CA2121698C Synthesis of human procollagens and collagens in recombinant dna systems |
| 05/14/2010 | WO2010054321A2 Methods of treating autoimmune disorders and/or inflammatory disorders |
| 05/14/2010 | WO2010053182A1 Kynurenine production inhibitor |
| 05/14/2010 | WO2010053165A1 Vitamin d3 lactam derivative |
| 05/14/2010 | WO2010052734A1 Substituted benzfurochromenes and related compounds for the prevention and treatment of bone related disorders |
| 05/14/2010 | WO2010052508A1 Ligands of vitamin d nuclear receptors with cell maturation promotion factors |
| 05/14/2010 | WO2010052027A1 Combinational therapy comprising dhodh inhibitor and methotrexate for treating autoimmune disease |
| 05/14/2010 | WO2010025267A3 Methods of modulating gastrointestinal tract flora levels with alkaline phosphatase |
| 05/14/2010 | WO2010011599A3 Pimethixene derivatives for promoting bone growth |
| 05/14/2010 | WO2010006184A3 Small-molecule inhibitors of hif and angiogenesis |
| 05/14/2010 | WO2009145814A9 Pyrimidines and pyridines useful as inhibitors of protein kinases |
| 05/14/2010 | WO2009041798A8 Pharmaceutical compositions combining a nonsteroidal anti-inflammatory agent and a xanthine oxidase inhibiting agent, which can be used to control and treat gout, gouty arthritis and related diseases |
| 05/14/2010 | CA2742910A1 Combinational therapy comprising dhodh inhibitor and methotrexate for treating autoimmune disease |
| 05/13/2010 | US20100121459 Tetra Calcium Phosphate Based Organophosphorus Compositions and Methods |
| 05/13/2010 | US20100121255 Compound |
| 05/13/2010 | US20100120923 Adhesive complex coacervates and methods of making and using thereof |
| 05/13/2010 | US20100120920 N-acetylcysteine amide (nac amide) for the treatment of diseases and conditions associated with oxidative stress |
| 05/13/2010 | US20100120912 Esters of capsaicinoids as dietary supplements |
| 05/13/2010 | US20100120902 Standarized bioactive herbal extracts |
| 05/13/2010 | US20100120875 Use of 4-[(4-thiazolyl)phenoxy]alkoxy-benzamidine derivatives for treatment of osteoporosis |
| 05/13/2010 | US20100120865 thiazol-2-yl-urea derivatives such as 3-{3-[4-Methyl-5-(4-pyrazol-1-yl-phenyl)-thiazol-2-yl]-ureido}-N-pyridin-3-yl-propionamide, used in the treatment of diseases ameloriated by inhibition of phosphatidylinositol 3-kinase, particularly inflammatory, allergic or autoimmune conditions |
| 05/13/2010 | US20100120858 Piperidine Derivatives |
| 05/13/2010 | US20100120846 Trpv1 antagonists |
| 05/13/2010 | US20100120807 Compounds and compositions as modulators of gpr119 activity |
| 05/13/2010 | US20100120802 Novel Anti-Inflammatory and Analgesic Heterocyclic Amidines that Inhibit Nitrogen Oxide (NO) Production |
| 05/13/2010 | US20100120794 Cycloalkylamino Acid Derivatives |
| 05/13/2010 | US20100120778 Quinoxaline-based lxr modulators |
| 05/13/2010 | US20100120772 P38 kinase inhibitors |
| 05/13/2010 | US20100120767 Pyrimidothiophene Compounds |
| 05/13/2010 | US20100120766 Substituted Pteridines |
| 05/13/2010 | US20100120756 Phenothiazine modulators of h1 receptors |
| 05/13/2010 | US20100120741 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| 05/13/2010 | US20100120731 3-([1,2,4]triazolo [4,3-a]pyridin-7-yl)benzamide derivatives |
| 05/13/2010 | US20100120723 Pharmaceutical composition comprising a hot-melt granulated lubricant |
| 05/13/2010 | US20100120722 Heterocyclic compounds for preventing and treating disorders associated with excessive bone loss |
| 05/13/2010 | US20100120705 Compositions and products containing s-equol, and methods for their making |
| 05/13/2010 | US20100120665 Treatment of diseases characterized by inflammation |
| 05/13/2010 | US20100119621 Process for preparing oral calcium compositions |
| 05/13/2010 | US20100119611 Delivery of a Bioactive Material |